Especially, centrally active ACE inhibitors with brain‐penetrating ability that prevent the progression of neurodegeneration potentially protect against the development of AD (Fazal et al., 2017; Gao et al., 2013; O'Caoimh et al., 2014; Sink et al., 2009). This evidence concerns the gene ACE and Alzheimer disease.